SNOW vs TBPH · rev $1.55B vs P/E 7.5, rev $38.4M
Snowflake Inc. (SNOW) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
SNOW currently screens at market cap $73.90B. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the SNOW and TBPH stock pages for the full models.
Not investment advice.